stars 1 stars 2 stars 3

We are a dedicated team of animal health professionals with a passion for solving the challenges of managing chronic pain in companion animals. We are harnessing the power of the novel radiotherapeutic Synovetin OA (tin-117m) to treat canine elbow arthritis. Synovetin OA targets inflammatory macrophages in the synovium and synovial fluid to break the cycle of inflammation and provide very long-lasting relief and improved mobility. Synovetin OA is administered in a minimally-invasive, outpatient procedure, convenient for the pet, pet parent and veterinary professional.

Synovetin OA® Questions

The Synovetin OA® annual revenue was $3 million in 2026.

Immanuel Thangaraj is the Co-Founder of Synovetin OA®.

3 people are employed at Synovetin OA®.

Synovetin OA® is based in Buford, Georgia.

The NAICS codes for Synovetin OA® are [812, 81].

The SIC codes for Synovetin OA® are [729, 72].

Top Synovetin OA® Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users